tradingkey.logo

Cryoport Inc

CYRX
查看详细走势图
8.720USD
+0.120+1.40%
收盘 02/06, 16:00美东报价延迟15分钟
436.60M总市值
6.92市盈率 TTM

Cryoport Inc

8.720
+0.120+1.40%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.40%

5天

-8.31%

1月

-18.20%

6月

+6.34%

今年开始到现在

-9.17%

1年

+28.05%

查看详细走势图

TradingKey Cryoport Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Cryoport Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力较大。当前估值合理,在货运与物流服务行业排名31/75位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价13.22。中期看,股价处于平稳状态。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Cryoport Inc评分

相关信息

行业排名
31 / 75
全市场排名
161 / 4521
所属行业
货运与物流服务

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Cryoport Inc亮点

亮点风险
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
利润高增长
公司净利润处于行业前列,最新年度总收入228.38M美元
估值低估
公司最新PB估值0.92,处于3年历史低位
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值58.81K
活跃度增加
近期活跃度增加,过去20天平均换手率0.90

分析师目标

根据 9 位分析师
买入
评级
13.222
目标均价
+42.17%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Cryoport Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Cryoport Inc简介

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
公司代码CYRX
公司Cryoport Inc
CEOShelton (Jerrell Wilson)
网址https://www.cryoport.com/
KeyAI